Bioventus (BVS) EBT Margin (2020 - 2026)
Bioventus' (BVS) quarterly EBT Margin came in at 9.99% in Q2 2026, up 301.0% on a YoY basis from 2.49% in Q2 2025, and up 192.18% quarter-over-quarter from 3.42% in Q1 2026.
Powered by 
Analysis
Bioventus (BVS) EBT Margin (2020 - 2026) Analysis & Trends
Bioventus (BVS) has reported EBT Margin for 7 consecutive years, with 9.99% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 301.0% year-over-year to 9.99%; the trailing twelve-month figure through Jun 2026 stood at 6.64% (up 636.0% YoY), and the FY2025 full-year result was 4.53%, up 1366.0% from the prior year.
- EBT Margin improved to 9.99% in Q2 2026 per BVS's latest filing, from 3.42% in the prior quarter.
- Across five years, EBT Margin topped out at 9.99% in Q2 2026 and bottomed at 101.47% in Q4 2022.
- Historically, EBT Margin has averaged 14.13% across 5 years, with a median of 4.01% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 9858 bps in 2022, then soared 9469 bps in 2023.
- Over 5 years, EBT Margin stood at 25.78% in 2022, then soared by 76 bps to 6.21% in 2023, then surged by 99 bps to 0.03% in 2024, then surged by 26065 bps to 8.96% in 2025, then climbed by 12 bps to 9.99% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 9.99%, 3.42%, and 8.96% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.32% |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | 9.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 9.99% |
| Mar 28, 2026 | 3.42% |
| Dec 31, 2025 | 8.96% |
| Sep 27, 2025 | 3.37% |
| Jun 28, 2025 | 6.98% |
| Mar 29, 2025 | -2.76% |
| Dec 31, 2024 | -0.03% |
| Sep 28, 2024 | -3.78% |
| Jun 29, 2024 | -27.48% |
| Mar 30, 2024 | -4.23% |
| Dec 31, 2023 | -6.21% |
| Sep 30, 2023 | -6.78% |
| Jul 1, 2023 | -3.17% |
| Apr 1, 2023 | -84.13% |
| Dec 31, 2022 | -25.78% |
| Oct 1, 2022 | -101.47% |
| Jul 2, 2022 | -4.62% |
| Apr 2, 2022 | -16.66% |
| Dec 31, 2021 | -2.11% |
| Oct 2, 2021 | -2.89% |